Award Categories include Device Design, Innovation and Leadership which recognize achievements in manufacturing, technology, materials and team performance.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.
Monogram’s surgeon-guided semi- and fully autonomous robotic technologies will add differentiated capabilities to Zimmer Biomet’s suite of customer-centric technology solutions.
MNVC will feature dozens of orthopedic companies and provide attendees with a glimpse of the unmet needs that startups are trying to address.
This strategic move provides Poly Medicure with an entry point into the large global orthopedics market, particularly in the trauma and extremities segment.
The partnership expands SMAIO’s business in the U.S. and drives adoption of its new open platform for customized implant solutions.
Within 3Q25, these companies debuted products to help fix our fractures and deformities in shoulders, pelvis and toes throughout our ages.
The next-generation, radiation-free optical navigation complements the Highridge portfolio of enabling technologies.
VergenixSTR for the treatment of tendinopathy is now available in Poland.
This collaboration will expand access of Elute’s BonVie+ bone graft substitute to physicians and patients at U.S. VA and DoD medical facilities worldwide.
New systems seek to simplify use of the technology by tapping into equipment in the O.R., offering ASC-friendly sizes and including AI applications.
This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology Platform for children and adolescents, a population at great risk for acute compartment syndrome.
Synthecure is a 100% synthetic calcium sulfate bone void filler that can be used directly at the site of infection in bone cavities and defects.
Acquired lines include the FlareHawk and Toro expandable interbody fusion systems, as well as the LineSider pedicle screw.
Biedermann Motech will cease direct distribution of its spinal and extremity product lines in the U.S. market in the near future.
Aurelio Sahagun will succeed Darin Johnson as new company CEO upon successful closing of the sale of the company.
The acquisition enhances Tenon’s sacroiliac joint fusion capabilities with a multi-product, multi-approach solution.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.